This is the stuff and people DECN is dealing with?
From the yahoo board:
Poop4 hours ago
So here is the work of that crazy man Poster.
HELLO SEC CHAIRMAN, FBI AND MR. KEITH BERMAN:
Please note the email message below from Mr. Keith Berman that is currently being investigated for matters relating to his stock trading in the pink OTC.
1). Upon information and belief, Mr. Berman has been issuing misleading press releases that attracted the attention of shareholders, that purchased the stock on the belief that DECISION DIAGNOSTICS CORP/PHARMA TECH SOLUTIONS produced a 15 second COVID-19 test.
2). Upon information produced by Mr. Keith Berman in his written press releases, Mr. Berman submitted documentation obtaining an FDA “Pre- Emergency Use Authorization serial number “PEUA200232,” for a product alleged as “Genviro Swift COVID-19, 15 Second Test.”
3). It is also upon information and belief that Mr. Berman and/or his companies Decision diagnostics and or Pharma tech Solutions does not have any such test in existence and also mislead the USFDA.
4). It is also upon information and belief that Mr. Berman clearly stated and indicated and admitted to not having any “15 Second Test, Genviro Swift,” by the indications in Mr. Berman’s own written press release, dated April 7, 2020, for example, at web link:
https://finance.yahoo.com/news/decn-receives-...00818.html
“Keith Berman, CEO of Decision Diagnostics commented, "We filed our final application with the FDA for EUA approval on April 3, 2020, taking out all reference to our at-home use Covid-19 kit. We submitted the application late in the afternoon EDT, and incredibly we received our Pre-EUA Acknowledgement the morning of April 4, 2020, less than 24 hours later, and on the weekend. We were so stunned by the rapid acknowledgment that we waited almost two days to inquire whether the acknowledgment was what we have come to know as the "Pre-EUA." We were assured that this letter from the FDA and the device serial number assigned are exactly what we had been hoping for."
“As early as Saturday April 4, it was clear that the FDA review staff was aware that our methodology was different than those slower and older methods that had received FDA EUAs, or were in review. Although the testing requested will be rigorous, it appears that testing will require 30 known Covid-19 positive samples and 30 known Covid-19 negative samples, all samples based on venous blood. The company is now looking to contract with a hospital or commercial laboratory to complete this testing.”
5). Mr. Berman admired to not having the “GENVIRO SWIFT 15 Second Test by the following portion of the press release: “
Mr. Berman continued, "Upon receipt of these acknowledgments from the FDA, we contacted our partners in Korea, and provided specifications for all of the major components required for the GenViro!™ kit that are not used or a part of our GenUltimate! TBG product. Today our partners began ordering these components to begin build, assembly and bench testing for the post-prototype version of GenViro!™, Point of Care kit. These activities will become part of the completion of our Design Specifications file and Design History file for Genviro!™, and are necessary components of all FDA cleared medical devices. "
6). Upon information and belief, directly related to Mr. Berman’s press release, is reason to believe that Mr. Berman knowingly mislead investors and the public.
7). THE SECURITIES AND EXCHANGE COMMISSION ALSO CITED THE 15 second test in the SEC report that resulted in the trading suspension of “DECN” stock at the following SEC link: https://www.sec.gov/litigation/suspensions/20...8735-o.pdf
. Also Mr. Berman has sent me a malicious email below, in response to my emailed request to work for Decision Diagnostics last week.
Thank you for your attention in this matter,
Raffi Stepanian
Who is this guy?
https://unbelievable-facts.com/2019/07/raffi-stepanian.html
From the yahoo board:
Poop4 hours ago
So here is the work of that crazy man Poster.
HELLO SEC CHAIRMAN, FBI AND MR. KEITH BERMAN:
Please note the email message below from Mr. Keith Berman that is currently being investigated for matters relating to his stock trading in the pink OTC.
1). Upon information and belief, Mr. Berman has been issuing misleading press releases that attracted the attention of shareholders, that purchased the stock on the belief that DECISION DIAGNOSTICS CORP/PHARMA TECH SOLUTIONS produced a 15 second COVID-19 test.
2). Upon information produced by Mr. Keith Berman in his written press releases, Mr. Berman submitted documentation obtaining an FDA “Pre- Emergency Use Authorization serial number “PEUA200232,” for a product alleged as “Genviro Swift COVID-19, 15 Second Test.”
3). It is also upon information and belief that Mr. Berman and/or his companies Decision diagnostics and or Pharma tech Solutions does not have any such test in existence and also mislead the USFDA.
4). It is also upon information and belief that Mr. Berman clearly stated and indicated and admitted to not having any “15 Second Test, Genviro Swift,” by the indications in Mr. Berman’s own written press release, dated April 7, 2020, for example, at web link:
https://finance.yahoo.com/news/decn-receives-...00818.html
“Keith Berman, CEO of Decision Diagnostics commented, "We filed our final application with the FDA for EUA approval on April 3, 2020, taking out all reference to our at-home use Covid-19 kit. We submitted the application late in the afternoon EDT, and incredibly we received our Pre-EUA Acknowledgement the morning of April 4, 2020, less than 24 hours later, and on the weekend. We were so stunned by the rapid acknowledgment that we waited almost two days to inquire whether the acknowledgment was what we have come to know as the "Pre-EUA." We were assured that this letter from the FDA and the device serial number assigned are exactly what we had been hoping for."
“As early as Saturday April 4, it was clear that the FDA review staff was aware that our methodology was different than those slower and older methods that had received FDA EUAs, or were in review. Although the testing requested will be rigorous, it appears that testing will require 30 known Covid-19 positive samples and 30 known Covid-19 negative samples, all samples based on venous blood. The company is now looking to contract with a hospital or commercial laboratory to complete this testing.”
5). Mr. Berman admired to not having the “GENVIRO SWIFT 15 Second Test by the following portion of the press release: “
Mr. Berman continued, "Upon receipt of these acknowledgments from the FDA, we contacted our partners in Korea, and provided specifications for all of the major components required for the GenViro!™ kit that are not used or a part of our GenUltimate! TBG product. Today our partners began ordering these components to begin build, assembly and bench testing for the post-prototype version of GenViro!™, Point of Care kit. These activities will become part of the completion of our Design Specifications file and Design History file for Genviro!™, and are necessary components of all FDA cleared medical devices. "
6). Upon information and belief, directly related to Mr. Berman’s press release, is reason to believe that Mr. Berman knowingly mislead investors and the public.
7). THE SECURITIES AND EXCHANGE COMMISSION ALSO CITED THE 15 second test in the SEC report that resulted in the trading suspension of “DECN” stock at the following SEC link: https://www.sec.gov/litigation/suspensions/20...8735-o.pdf
. Also Mr. Berman has sent me a malicious email below, in response to my emailed request to work for Decision Diagnostics last week. Thank you for your attention in this matter,
Raffi Stepanian
Who is this guy?
https://unbelievable-facts.com/2019/07/raffi-stepanian.html
